Breast cancer prevention

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Early detection, combined with targeted and more effective therapies, has led to significant reductions in breast cancer-related deaths. Approximately 90 % of women diagnosed with early-stage breast cancer are alive and disease-free 10 years after diagnosis. Despite these successes, breast cancer still affects 1 in 8 women and remains a major cause of morbidity and mortality in women of every race and ethnicity and continues as a major cause of death in women 35–54 years. These facts combined with the increasing rates of breast cancer worldwide with industrial development, especially among previously low-risk regions and low-risk populations, have created new concerns (Minami et al., Int J Cancer 108(6):901–906, 2004; Althuis et al., Int J Epidemiol 34(2):405–412, 2005; Bosetti et al., Ann Oncol 16(3):489–511, 2005; Newman and Vogel, Surg Clin North Am 87(2):307–316, 2007; Jemal, CA Cancer J Clin 61:69–90, 2011). The latter is a particularly worrisome trend for regions, and populations where use of screening and access to advances in treatment remain limited and mortality rates high (Yip and Taib, Future Oncol 8(12):1575–1583, 2012). Given that the worldwide burden of breast cancer is nearly 1.4 million new cases, a quarter of all cancer diagnoses in women with just under half a million lives lost annually to the disease (http://​globocan.​iarc.​fr/​factsheet.​asp), the prevention and early detection of breast cancer remains a major global public health priority.

Original languageEnglish (US)
Title of host publicationFundamentals of Cancer Prevention, Third Edition
PublisherSpringer Berlin Heidelberg
Pages445-489
Number of pages45
ISBN (Print)9783642389832, 9783642389825
DOIs
StatePublished - Jan 1 2014

Fingerprint

Breast Neoplasms
Health Priorities
Neoplasms
Breast Diseases
Mortality
Viperidae
Early Detection of Cancer
Population
Cause of Death
Public Health
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Thompson, P. A., Laukaitis, C. M., & Stopeck, A. T. (2014). Breast cancer prevention. In Fundamentals of Cancer Prevention, Third Edition (pp. 445-489). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-38983-2_15

Breast cancer prevention. / Thompson, Patricia A.; Laukaitis, Christina M; Stopeck, Alison T.

Fundamentals of Cancer Prevention, Third Edition. Springer Berlin Heidelberg, 2014. p. 445-489.

Research output: Chapter in Book/Report/Conference proceedingChapter

Thompson, PA, Laukaitis, CM & Stopeck, AT 2014, Breast cancer prevention. in Fundamentals of Cancer Prevention, Third Edition. Springer Berlin Heidelberg, pp. 445-489. https://doi.org/10.1007/978-3-642-38983-2_15
Thompson PA, Laukaitis CM, Stopeck AT. Breast cancer prevention. In Fundamentals of Cancer Prevention, Third Edition. Springer Berlin Heidelberg. 2014. p. 445-489 https://doi.org/10.1007/978-3-642-38983-2_15
Thompson, Patricia A. ; Laukaitis, Christina M ; Stopeck, Alison T. / Breast cancer prevention. Fundamentals of Cancer Prevention, Third Edition. Springer Berlin Heidelberg, 2014. pp. 445-489
@inbook{96a0f0b14b2c4ce8be75d7bfcf34804d,
title = "Breast cancer prevention",
abstract = "Early detection, combined with targeted and more effective therapies, has led to significant reductions in breast cancer-related deaths. Approximately 90 {\%} of women diagnosed with early-stage breast cancer are alive and disease-free 10 years after diagnosis. Despite these successes, breast cancer still affects 1 in 8 women and remains a major cause of morbidity and mortality in women of every race and ethnicity and continues as a major cause of death in women 35–54 years. These facts combined with the increasing rates of breast cancer worldwide with industrial development, especially among previously low-risk regions and low-risk populations, have created new concerns (Minami et al., Int J Cancer 108(6):901–906, 2004; Althuis et al., Int J Epidemiol 34(2):405–412, 2005; Bosetti et al., Ann Oncol 16(3):489–511, 2005; Newman and Vogel, Surg Clin North Am 87(2):307–316, 2007; Jemal, CA Cancer J Clin 61:69–90, 2011). The latter is a particularly worrisome trend for regions, and populations where use of screening and access to advances in treatment remain limited and mortality rates high (Yip and Taib, Future Oncol 8(12):1575–1583, 2012). Given that the worldwide burden of breast cancer is nearly 1.4 million new cases, a quarter of all cancer diagnoses in women with just under half a million lives lost annually to the disease (http://​globocan.​iarc.​fr/​factsheet.​asp), the prevention and early detection of breast cancer remains a major global public health priority.",
author = "Thompson, {Patricia A.} and Laukaitis, {Christina M} and Stopeck, {Alison T}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-3-642-38983-2_15",
language = "English (US)",
isbn = "9783642389832",
pages = "445--489",
booktitle = "Fundamentals of Cancer Prevention, Third Edition",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Breast cancer prevention

AU - Thompson, Patricia A.

AU - Laukaitis, Christina M

AU - Stopeck, Alison T

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Early detection, combined with targeted and more effective therapies, has led to significant reductions in breast cancer-related deaths. Approximately 90 % of women diagnosed with early-stage breast cancer are alive and disease-free 10 years after diagnosis. Despite these successes, breast cancer still affects 1 in 8 women and remains a major cause of morbidity and mortality in women of every race and ethnicity and continues as a major cause of death in women 35–54 years. These facts combined with the increasing rates of breast cancer worldwide with industrial development, especially among previously low-risk regions and low-risk populations, have created new concerns (Minami et al., Int J Cancer 108(6):901–906, 2004; Althuis et al., Int J Epidemiol 34(2):405–412, 2005; Bosetti et al., Ann Oncol 16(3):489–511, 2005; Newman and Vogel, Surg Clin North Am 87(2):307–316, 2007; Jemal, CA Cancer J Clin 61:69–90, 2011). The latter is a particularly worrisome trend for regions, and populations where use of screening and access to advances in treatment remain limited and mortality rates high (Yip and Taib, Future Oncol 8(12):1575–1583, 2012). Given that the worldwide burden of breast cancer is nearly 1.4 million new cases, a quarter of all cancer diagnoses in women with just under half a million lives lost annually to the disease (http://​globocan.​iarc.​fr/​factsheet.​asp), the prevention and early detection of breast cancer remains a major global public health priority.

AB - Early detection, combined with targeted and more effective therapies, has led to significant reductions in breast cancer-related deaths. Approximately 90 % of women diagnosed with early-stage breast cancer are alive and disease-free 10 years after diagnosis. Despite these successes, breast cancer still affects 1 in 8 women and remains a major cause of morbidity and mortality in women of every race and ethnicity and continues as a major cause of death in women 35–54 years. These facts combined with the increasing rates of breast cancer worldwide with industrial development, especially among previously low-risk regions and low-risk populations, have created new concerns (Minami et al., Int J Cancer 108(6):901–906, 2004; Althuis et al., Int J Epidemiol 34(2):405–412, 2005; Bosetti et al., Ann Oncol 16(3):489–511, 2005; Newman and Vogel, Surg Clin North Am 87(2):307–316, 2007; Jemal, CA Cancer J Clin 61:69–90, 2011). The latter is a particularly worrisome trend for regions, and populations where use of screening and access to advances in treatment remain limited and mortality rates high (Yip and Taib, Future Oncol 8(12):1575–1583, 2012). Given that the worldwide burden of breast cancer is nearly 1.4 million new cases, a quarter of all cancer diagnoses in women with just under half a million lives lost annually to the disease (http://​globocan.​iarc.​fr/​factsheet.​asp), the prevention and early detection of breast cancer remains a major global public health priority.

UR - http://www.scopus.com/inward/record.url?scp=84955626225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955626225&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-38983-2_15

DO - 10.1007/978-3-642-38983-2_15

M3 - Chapter

SN - 9783642389832

SN - 9783642389825

SP - 445

EP - 489

BT - Fundamentals of Cancer Prevention, Third Edition

PB - Springer Berlin Heidelberg

ER -